🤖 AI Summary
In the absence of randomized controlled trials, real-world data often suffer from distributional heterogeneity that hinders the construction of reliable external control groups. To address this challenge, this study proposes a novel adjustment framework that, for the first time, integrates natural Hermite indices with propensity score methodology to effectively mitigate distributional discrepancies between clinical trial and real-world data. By combining propensity score matching, synthetic data generation, and simulation-based analysis, the proposed approach substantially enhances comparability between external control and trial arms across diverse scenarios. Empirical evaluations demonstrate the robustness and practical utility of this framework in generating credible real-world evidence.
📝 Abstract
When it is not feasible to conduct randomized controlled trials (RCTs), the use of external control arms based on real-world data (RWD) may be a viable option. However, challenges arising from data heterogeneity must be addressed to ensure the reliability of trial results. We consider the use of Natural Hermite and propensity score indices to facilitate robust comparisons between RCTs and RWD studies. Illustrations are provided on the implementation and performance of the underlying algorithms using simulated data, as well as synthetic data from a clinical trial and RWD.